Hepatitis B reactivation in a chronic hepatitis C patient treated with ledipasvir and sofosbuvir: A case report

Clin Res Hepatol Gastroenterol. 2017 Mar;41(2):e17-e18. doi: 10.1016/j.clinre.2016.08.001. Epub 2016 Sep 3.

Authors

Pengcheng Ou¹, Zhixiong Fang², Jun Chen³

Affiliations

¹ Liver diseases center, the Second Xiangya hospital, Central South University, 410011 Changsha Hunan, China.
² Department of infectious disease, Xiangtan Central hospital, 120, Peace Road, 411199 Xiangtan, Hunan, China.
³ Liver diseases center, the Second Xiangya hospital, Central South University, 410011 Changsha Hunan, China. Electronic address: [email protected].

PMID: 27601170
DOI: 10.1016/j.clinre.2016.08.001

No abstract available

Publication types

Case Reports

MeSH terms

Antiviral Agents / therapeutic use*
Benzimidazoles / therapeutic use*
Drug Therapy, Combination
Fluorenes / therapeutic use*
Hepatitis B / complications
Hepatitis B / drug therapy*
Hepatitis C, Chronic / complications
Hepatitis C, Chronic / drug therapy*
Humans
Recurrence
Sofosbuvir / therapeutic use*
Time Factors
Treatment Outcome

Substances

Antiviral Agents
Benzimidazoles
Fluorenes
ledipasvir
Sofosbuvir